As far as we know, this is the first study to report elevated CRM1 expression as an independent prognostic marker for poor clinical course and overall survival in laryngeal cancer patients diagnosed with squamous cell carcinoma. The gene discussed is XPO1; the disease is laryngeal carcinoma.